- LifestyleRx pioneers Type 2 diabetes reversal, not just management, with 2,000 patients and a goal for a 95% reduction in diabetes.
- MARC technology doubles tumor-clearing power, aiming to transform costs in various cardiometabolic diseases.
- They have a vision to offset $15 spent on diabetes care.
Ever felt like the healthcare system needed a bit of a nudge, a fresh perspective? There are so many incurable diseases. People often lose hope and accept years of suffering. Maybe even we need a fresh perspective, and a little bit of faith in the healthcare system.
For those silently battling diabetes, the struggle is constant and often underestimated. Diabetes isn't just about glucose levels; it's a battle that can lead to severe consequences. Here’s where LifestyleRx comes in. This startup isn't just offering management; it's pioneering a path to reversal, promising a revolutionary shift in the daily struggles of individuals with diabetes.
The people behind the mission:
Jason Kerkvliet, CEO of LifestyleRx. He is a recovering EMR founder, a Princeton grad, delivering Type 2 Diabetes reversal to thousands of patients! Brendan Byrne, the Chief Medical Officer, is a lifestyle medicine physician and serial entrepreneur.
Jack Hilliard is a seasoned CPA with years of experience growing, scaling, and exiting tech-based companies. And lastly, Daniel Pfingstgraef, the CTO. He built his first EMR at the tender age of 14 and has studied Computer Science at Western University. Together, they form the team driving LifestyleRx.
What is LifestyleRx?
Let's cut to the chase – LifestyleRx is not just another diabetes management app. No, it's on a mission to reverse Type 2 diabetes. They guide patients through transformative lifestyle changes, all covered by insurance. And here's the kicker – they're not just talking; they've got 2,000 patients in the program today, and are adding 500 more each month.
The backstory:
But wait, why another diabetes startup, you ask? The diabetes market is flooded with solutions, yet the costs soar above $237 billion annually, impacting over 100 million Americans. LifestyleRx takes a different route. Instead of managing diabetes, they're all about reversing it. Their goal? Sustained drug-free remission, aiming not for a 5% reduction but a whopping 95%.
Cracking the diabetes code :
MARC, or Modular Actuation Receptor Complexes. These synthetic genes work to double the tumor-clearing power compared to conventional CAR-T cells. But LifestyleRx doesn't stop at oncology; they've got their eyes set on transforming costs across various cardiometabolic diseases. Think of it as a lifestyle prescription for a healthier future.
Making it work – Profitably:
It's all about provider leverage. LifestyleRx equips its doctors with technology that's nothing short of superpowers. They've built their EMR platform, ensuring every decision is backed by real patient data. Patients spend a couple of hours with physicians but get more than 20 times that in connection, learning through personalized content and interactive reports. The future? Leveraging LLMs to guide patients through changes, increases the provider leverage ratio.
Shrinking the market – Because health shouldn't break the bank:
Diabetes may be a $237 billion market, but LifestyleRx is here to shake things up. They're not just reversing diabetes; they're reversing the market, creating a $36 billion oasis of health. For every dollar spent on diabetes reversal, they offset a staggering $15 spent on diabetes care. And the best part? The dollars saved can fuel other essential aspects of the healthcare system.
As we navigate the complexities of healthcare and diseases, startups like LifestyleRx promise not just a nudge but a shift in the way we perceive and tackle chronic illnesses. It's a reminder that, sometimes, all it takes is a new perspective to transform lives.
Edited by Shruti Thapa
